PubMed Health⌕ Search

Biomedical subjects

M O Rocha

Publications and source records attributed to M O Rocha.

27 records · Page 2Linked to original sources
PubMedDate not supplied

[Chronic pulmonary form of schistosomiasis mansoni. Clinico-radiologic evaluation].

One hundred and fifteen patients with schistosomiasis mansoni were studied: 31 with a normal chest x-rays and no signs of pulmonary hypertension (PH) and 84 with x-rays compatible with cardiopulmonary abnormalities (73 without symptoms and 11 with symptoms of PH). The chronic pulmonary form (CPF) without pulmonary hypertension is frequent and benign. There was no association between the CPF and the hepatosplenic form (HEF), nor with age, sex or patient origin. Pulmonary hilum alterations were the most common x-ray findings, followed by parenchymatous abnormalities (micronodules). The CPF was associated with a low to medium worm burden. The incidence of CPF with pulmonary hypertension is low but usually related to significant heart abnormalities. It is more common in patients over 12 years, with the HEF of the disease and has no correlation with sex, race or place of birth. Chest x-ray alterations are seen with similar frequency both in parenchymatous and hilar regions.

Adolescent↗
PubMedDate not supplied

[Clinico-epidemiologic profile of Chagas disease patients attending an ambulatory referral center and proposal of a model of care for the Chagas patient under the perspective of a comprehensive health care].

A case-control study to analyse clinical and epidemiological data of 842 patientes seen in an outpatient ward reference center for chagas disease in Belo Horizonte, Brazil, from 1985 to 1992. It was verified that these patients were in a average age of 37.78 years; lower literacy regardless of race, and, performed activities that demanded greater muscle effort (p < 0.05). The main mechanism for disease transmission proved to be the vectorial route. Disease-especific complaints prevailed in the above mentioned patients (p < 0.05). The most important abnormalities found in clinical examination were with cardiac sounds (OR: 2.96 95% CI: 1.29-4.09) and the presence of extrasystole (OR: 7.16 95% CI: 1.59-45.07). Imunofluorescence Test was more sensitive (94%) and specific (96%). It also had a PPV of 99% and e NPV of 83%. ELISA test carried out in 43 patientes did not yield false results. Indeterminate chronic phase (56%) or early stages of the disease prevailed. The findings of normal EKGs and abnormalities in 30% of the Holter tests, 41% of the exercise tests, 33% of the ECO tests and, 48% of normal chest x-ray with abnormal ECO, high lights the importance of caring out more detailed exams in specific situations. We hereby propose a care model for the Chagas disease patient, integrated to our State Health Plan stressing serologic tests, and training capable human resources committed to the development of integrated health care and the optimization of our referral and counter-referral system, thus issuing total care to the Chagas disease patient.

Adult↗
PubMedDate not supplied

[Indeterminate form of Chagas disease: considerations about diagnosis and prognosis].

The indeterminate form of Chagas' disease is defined by the absence of clinical, radiological and electrocardiographic manifestations of cardiac or digestive involvement in Trypanosoma cruzi chronic infected persons. When submitted to advanced cardiovascular tests, these patients may present significant abnormalities. However, the indeterminate form concept was reaffirmed as valid, since diagnostic criteria are simple and prognosis is benignant. In clinical practice, diagnostic difficulties are frequent, related to subjectivity and uncertain meaning of clinical, electrocardiographic and radiological findings. Moreover, indeterminate form prognosis is not equally good: after five to 10 years, a third of patients will have cardiopathy. Sudden death, a rare complication, may be the first manifestation of Chagas' disease. It is necessary to reappraise indeterminate form concept, redefining diagnostic criteria and therapeutic management. Clinical and noninvasive evaluation may allow individual risk stratification; therapeutic interventions may be beneficial in high risk groups. Since etiologic treatment may prevent cardiopathy, its role in indeterminate form management must be reassessed.

Chagas Cardiomyopathy↗